Maria and her colleagues believe the technique will facilitate the scale-up of autologous CAR-T cell therapy and bring down the cost of treatment. You can read the full article "Autologous CAR T-cell therapies supply chain: challenges and opportunities?" here
The Hub is a based in UCL Biochemical Engineering with spokes comprising researchers from Imperial College London and several other UK universities, along with a user group of manufacturers, who are working to address challenges within medicine manufacturing, business and regulatory frameworks to make medicines cheaper and more widely available to patients.
Dr Papathanasiou explained: “Every aspect of this process needs to be carefully planned for it to operate on a larger scale, from storage facilities in clinical and manufacturing settings to the use of cloud-based platforms for tracking samples across their journey.”
Director's Summer Reading List 2025
Recommendations for your Summer reading from IGP's Director, Professor Henrietta L. Moore.
23 Jun 2025
New hub to harness the power of microbes to turn waste into valuable products
UCL Biochemical Engineering is part of a pioneering new hub that is set to transform UK manufacturing by converting industrial waste into valuable, sustainable chemicals and materials.
19 Jun 2025
Pathways to Sustainable Prosperity in Ukraine: IGP launches Building Bridges White Paper at Somerset
The Institute for Global Prosperity launched its Building Bridges for Ukraine White Paper on 9 June at Somerset House during the London Design Biennale. Eva Coulibaly-Willis reports on the event.
19 Jun 2025
